Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,680 annual reports · 4,010 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 53 of 640 · 7,680 filings

  • Infleqtion (INFQ) FY2025 10-K risk factors
    80 risks

    Infleqtion is an early-stage quantum computing and sensing company facing significant commercialization barriers and unproven market demand. The company is heavily dependent on U.S. government contracts and cloud partnerships that pose distinct revenue risks. Internal control weaknesses and a history of substantial net operating losses threaten ongoing financial stability.

    Filed Mar 31, 2026
  • Professional Diversity Network (IPDN) FY2025 10-K risk factors
    38 risks4 new4 reworded

    The company expanded into musical copyrights, digital assets and Web3 initiatives despite limited experience and uncertain returns.

    Filed Mar 31, 2026
  • Israel Acquisitions (ISRL) FY2025 10-K risk factors
    70 risks2 new3 dropped4 reworded

    The company was delisted from Nasdaq in January 2026 and now trades on OTC Markets. Operating cash fell to $6,938 with a working capital deficit of $2,581,616. Regional conflict disclosures expanded to include Iran and Hezbollah alongside Hamas.

    Filed Mar 31, 2026
  • Iveda Solutions (IVDA) FY2025 10-K risk factors
    38 risks1 dropped2 reworded

    The company relies heavily on a small group of Taiwan-based enterprise customers for the majority of its revenue. Accumulated losses reached approximately $56 million, though annual net losses slightly decreased to $3.2 million.

    Filed Mar 31, 2026
  • J.Jill (JILL) FY2026 10-K risk factors
    60 risks3 new1 dropped7 reworded

    J.Jill faces rising tariff costs and elimination of de minimis duty-free exemptions impacting inventory margins.

    Filed Mar 31, 2026
  • Kairos Pharma (KAPA) FY2025 10-K risk factors
    93 risks2 new1 dropped2 reworded

    New risks focus on rapid U.S. policy changes, including taxation and healthcare, and reduced access to debt and equity capital.

    Filed Mar 31, 2026
  • Keel Infrastructure (KEEL) FY2025 10-K risk factors
    222 risks

    Keel Infrastructure Corp. faces concentration risks in scaling mining hardware and securing high-performance computing equipment for AI data centers.

    Filed Mar 31, 2026
  • Kodiak Sciences (KOD) FY2025 10-K risk factors
    93 risks7 new1 dropped10 reworded

    Kodiak highlights new clinical pipeline updates for tarcocimab, KSI-501, and KSI-101. International trade policy risks and generative AI data risks are added. Clinical trial outcome disclosures and regulatory compliance updates are reworded.

    Filed Mar 31, 2026
  • Kroger (KR) FY2026 10-K risk factors
    117 risks15 new19 dropped75 reworded

    Kroger incurred $2.5 billion in fulfillment network impairment and related charges impacting operating results. eCommerce sales grew 16% in 2025, driven by strong demand for delivery solutions. The company reduced finance lease liabilities through a cash termination payment to Ocado.

    Filed Mar 31, 2026
  • KULR Technology Group (KULR) FY2025 10-K risk factors
    50 risks11 new11 dropped20 reworded

    KULR added new digital asset mining and bitcoin treasury risks, expanding beyond engineered materials and energy management. Customer concentration intensified, with two customers representing 28 percent of energy revenue and one customer representing 100 percent of mining revenue. CEO Michael Mo's voting control via Series A Preferred Stock rose to 97.30 percent.

    Filed Mar 31, 2026
  • LENSAR (LNSR) FY2025 10-K risk factors
    80 risks8 new2 dropped18 reworded

    Terminated merger with Alcon created substantial legal, financial, and retention risks for the company this year. Federal net operating losses increased to $52.6 million while regulatory disclosures shifted to smaller reporting company status. AI and medical device compliance frameworks expanded significantly.

    Filed Mar 31, 2026
  • LanzaTech Global (LNZA) FY2025 10-K risk factors
    74 risks14 new9 dropped14 reworded

    LanzaTech faces severe going-concern doubts requiring external financing that heavily dilutes current common stockholders.

    Filed Mar 31, 2026

Companies covered

4,010 companies

371 more under A